Access
-
Merck, Serum Institute to develop and expand access to pneumococcal conjugate vaccine
Merck and Serum Institute of India Limited announced an agreement to work together to develop and commercialize a pneumococcal conjugate vaccine (PCV) for use in the emerging and developing world countries. It is estimated that one out of every two c…
Access | 04 August 2011
-
Gilead expands access program for medications in developing world
Licenses rights to HIV pipeline products to Indian partners
Access | 13 July 2011
-
Bristol-Myers Squibb signs new agreement to expand access to Reyataz
Bristol-Myers Squibb Company announced a new agreement to expand access to Reyataz (atazanavir sulfate). The immunity-from-suit agreement signed with Matrix Laboratories Limited, a Mylan Company, enables the generic company to manufacture and sell at…
Access | 28 June 2011
-
GSK tackles problem of access to medicines
Providing access to medicines in developing countries is a challenge. GSK is taking on this challenge through a multi-faceted approach. Christophe Weber, SVP and regional director Asia Pacific GSK, gave an in-depth presentation at the Regional Media …
Access | 06 November 2010
-
Fluidigm Releases Access Array System
Fluidigm Corporation has announced the release of its 48.48 Access Array integrated fluidic chip (IFC) for 454 FLX users who are active in Amplicon Tagging. This access array IFC automatically generates emulsion Polymerase Chain Reaction (emPCR)-read…
Access | 01 February 2010
-
Water Purification Accessory for Trace Elemental Analysis
Millipore Corporation has announced the availability of the Q-POD Element unit. Designed for use with the Milli-Q Integral and Milli-Q Advantage systems, the device ensures delivery of ultrapure water with low levels of elemental contamination (singl…
Access | 24 November 2009
-
Sigma-Aldrich Provides Online Access to Stem Cell Research
Sigma-Aldrich has announced the launch of an online web portal that provides researchers with access to products developed for advanced stem cell research. The portal features over 1,100 products – from isolation, characterization, expansion, diffe…
Access | 26 March 2009
-
Accessing GMP-Grade Stem Cell Lines in Large Pharma Company
ES Cell International (ESI) has entered into an agreement with a prominent international pharmaceutical company to assess ESI’s proprietary good manufacturing practice-grade (GMP-grade) human embryonic stem cell (hESCs) lines. The pharmaceutic…
Access | 01 October 2008
-
Accessing Healthcare in ASEAN
Healthcare leaders discuss sustainable healthcare solutions in ASEAN.
Access | 01 August 2008
-
PATH Study: $2-10B Needed For Vaccine Access For Influenza Pandemic Preparedness
If an influenza pandemic occurred in 2007, fewer than one-fifth of the approximately 13 billion vaccine doses needed to fully vaccinate the global population would be available within six months in a best-case scenario. A new study entitled Influ…
Access | 21 December 2007
